Area of research
Infectious Diseases · Microbiology
Research interest
Research interests include HIV/AIDS Research and Interventions, Reproductive tract infections research, HIV Research and Treatment, and Hydrogels: synthesis, properties, applications.
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development
Engineering and characterization of simplified vaginal and seminal fluid simulants
The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment
Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy
Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges
Multipurpose prevention technologies: Products in development
Assessment of topical microbicides to prevent HIV-1 transmission: Concepts, testing, lessons learned
“Set it and Forget it”: Women’s Perceptions and Opinions of Long-Acting Topical Vaginal Gels
Designing Preclinical Perceptibility Measures to Evaluate Topical Vaginal Gel Formulations: Relating User Sensory Perceptions and Experiences to Formulation Properties
Vaginally Delivered Tenofovir Disoproxil Fumarate Provides Greater Protection than Tenofovir against Genital Herpes in a Murine Model of Efficacy and Safety
Novel preclinical models of topical PrEP pharmacodynamics provide rationale for combination of drugs with complementary properties
Human cervicovaginal mucus contains an activity that hinders HIV-1 movement
A 90-Day Tenofovir Reservoir Intravaginal Ring for Mucosal HIV Prophylaxis
State of the art in intravaginal ring technology for topical prophylaxis of HIV infection.
PubMed 2012cited by 96position: first
Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection
Design of Tenofovir–UC781 Combination Microbicide Vaginal Gels
Development of a Combination Microbicide Gel Formulation Containing IQP-0528 and Tenofovir for the Prevention of HIV Infection